Patents by Inventor Jean-Michel Coutu

Jean-Michel Coutu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Embolizing sclerosing hydrogel
    Patent number: 9731043
    Abstract: A sclerosing embolizing hydrogel comprising from about 0.1% by weight to about 4.0% by weight of chitosan; from about 0.01M to about 1M of hydrochloric acid; from 0% by volume to about 40% by volume of iopamidol; from 0.5% by weight to about 25% by weight of ?-glycerophosphate disodium salt; and from about 0.05% by weight to about 4% by weight of sodium tetradecyl sulphate. Also a kit for synthesizing the hydrogel and a method using the hydrogel to treat a vascular defect in a subject.
    Type: Grant
    Filed: September 11, 2014
    Date of Patent: August 15, 2017
    Assignees: VAL-CHUM, LIMITED PARTNERSHIP, SOCOVAR S.E.C.
    Inventors: Sophie Lerouge, Giles Soulez, Ahmed Fatimi, Jean-Michel Coutu, Jean Raymond
  • Embolizing Sclerosing Hydrogel
    Publication number: 20140377187
    Abstract: A sclerosing embolizing hydrogel comprising from about 0.1% by weight to about 4.0% by weight of chitosan; from about 0.01 M to about 1 M of hydrochloric acid; from 0% by volume to about 40% by volume of iopamidol; from 0.5% by weight to about 25% by weight of ?-glycerophosphate disodium salt; and from about 0.05% by weight to about 4% by weight of sodium tetradecyl sulphate. Also a kit for synthesizing the hydrogel and a method using the hydrogel to treat a vascular defect in a subject.
    Type: Application
    Filed: September 11, 2014
    Publication date: December 25, 2014
    Inventors: Sophie Lerouge, Giles Soulez, Ahmed Fatimi, Jean-Michel Coutu, Jean Raymond
  • Embolizing sclerosing hydrogel
    Patent number: 8840867
    Abstract: A sclerosing embolizing hydrogel comprising from about 0.1% by weight to about 4.0% by weight of chitosan; from about 0.01M to about 1M of hydrochloric acid; from 0% by volume to about 40% by volume of iopamidol; from 0.5% by weight to about 25% by weight of ?-glycerophosphate disodium salt; and from about 0.05% by weight to about 4% by weight of sodium tetradecyl sulphate. Also a kit for synthesizing the hydrogel and a method using the hydrogel to treat a vascular defect in a subject.
    Type: Grant
    Filed: May 20, 2011
    Date of Patent: September 23, 2014
    Assignees: Val-Chum Limited Partnership, Socovar S.E.C.
    Inventors: Lerouge Sophie, Gilles Soulez, Ahmed Fatimi, Jean-Michel Coutu, Jean Raymond
  • Embolizing Sclerosing Hydrogel
    Publication number: 20110286925
    Abstract: A sclerosing embolizing hydrogel comprising from about 0.1% by weight to about 4.0% by weight of chitosan; from about 0.01M to about 1M of hydrochloric acid; from 0% by volume to about 40% by volume of iopamidol; from 0.5% by weight to about 25% by weight of ?-glycerophosphate disodium salt; and from about 0.05% by weight to about 4% by weight of sodium tetradecyl sulphate. Also a kit for synthesizing the hydrogel and a method using the hydrogel to treat a vascular defect in a subject.
    Type: Application
    Filed: May 20, 2011
    Publication date: November 24, 2011
    Inventors: Sophie Lerouge, Gilles Soulez, Ahmed Fatimi, Jean-Michel Coutu, Jean Raymond